Showing results (511-520 of 523) with videos related to
Sort By:
Pageof 53
International Journal of Dermatology|May 18, 2026
Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An UpdatePavel V Chernyshov, Gregor Jemec, Andrew Finlay, et al.JAMA Network Open|February 16, 2024
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in EuropeLara V Maul, Dagmar Jamiolkowski, Rebecca A Lapides, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 24, 2023
Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate-to-severe atopic dermatitis: Analyses of TREATgermany registry dataThomas Birkner, Doreen Siegels, Luise Heinrich, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 30, 2026
Patient treatment needs in atopic dermatitis: A real-world cohort studyKristina Ludemann, Stephan Traidl, Angela Cornelius, et al.The British Journal of Dermatology|July 27, 2022
Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registryDora Stölzl, Nicole Sander, Annice Heratizadeh, et al.Acta Dermato-Venereologica|January 23, 2023
Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermanyElke Weisshaar, Philipp Bentz, Christian Apfelbacher, et al.JAMA Dermatology|May 1, 2024
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis CouncilSiew Eng Choon, Peter van de Kerkhof, Johann E Gudjonsson, et al.Allergologie Select|June 22, 2026
Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactationThomas Werfel, Annice Heratizadeh, Matthias Augustin, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 24, 2026
Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativaGeorgios Nikolakis, Erkan Alpsoy, Florian Anzengruber, et al.Pageof 53